Alcohol septal ablation for obstructive hypertrophic cardiomyopathy was associated with greater rate of 10-year all-cause death compared with septal myectomy, researchers reported.
According to data published in the Journal of the American College of Cardiology, adjustment for comorbidities failed to attenuate the elevated long-term mortality risk tied to alcohol septal ablation for obstructive hypertrophic cardiomyopathy (HCM) compared with myectomy.
“Over the past 2 decades, there has been an ongoing debate regarding the relative merits of septal myectomy vs. alcohol septal ablation for